NTEK B

Novotek

Market Cap 291.5M
0.00
Today
Day High
N/A
27.5
Day Low
N/A
Day Open
27.50
Prev Close
27.50
VWAP
N/A
Volume
0K
Turnover
0.000M
Top Broker
VWAP
27.7
Avg Volume
5K
Avg Turnover
0.140M
Top Brokers
AVA/NRD
VWAP
27.7
Avg Volume
5K
Avg Turnover
0.149M
Top Brokers
AVA/NRD
VWAP
27.2
Avg Volume
6K
Avg Turnover
0.165M
Top Brokers
AVA/NRD
52 week summary
Price Range
17.9
Last
31.0
Beta
N/A
Market Cap
291.5M
Total Return
53.7%
Trailing P/E
N/A
Div Yield
N/A%
Shares Outstanding
10.6M
Next Earnings Date
15 Feb
Stock Exchange
NASDAQ Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.


Relative Price Strength
Change 3 Months 11.9%
Change 12 Months 33.7%
Volume Trend
Average Volume 10 vs 60 Days -46.7%
Price VS
52 Week High -11.3%
50 Day Moving Average -0.4%
200 Day moving Average 9.5%

Add article markers

Compare Novotek to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
  • Management
  • Tobias Antius, CEO
  • Executive board
  • Göran Andersson, Chairman of the board
Source: Millistream
Major Owners Equity Votes
Noveko Syd 12.7%
56.0%
Arvid Svensson Invest AB 24.9%
10.9%
Novoplan 5.6%
8.0%
Avanza Pension 8.9%
3.9%
JPMEL- Stockholm Branch 5.7%
2.5%
Source: Millistream
Timeframe Transactions Net Shares
Last 12 weeks
0 Purchases
+ 0
0 Sales
- 0
Last 24 weeks
0 Purchases
+ 0
0 Sales
- 0
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Catalyst Potential is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Millistream FI
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow

Estimated Values is behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.


Source: Redeye